Dr. Guillermo Luis Chantada

Dr Guillermo Luis Chantada graduated from the University of Buenos Aires, Argentina and completed his postgraduate training in Clinical Pediatrics and Pediatric Hematology- Oncology at the Hospital JP Garrahan at Buenos Aires where he served for 31 years. He is an associate member of the Oncology Service of the Hospital Sant Joan de Déu Hospital, Barcelona, Spain. He is Principal Researcher of the National Council of Research in Argentina (CONICET). He is the Scientific Director at the Pediatric Hemato-Oncology Service of the Hospital Universitario Austral, Argentina and at the Hemato-oncology service of the Hospital Pereira Rossell in Montevideo, Uruguay.

His major contributions are in the area of translational research in retinoblastoma where he worked the identification of innovative treatments, the characteristics of this tumor in developing countries and in depicting its mechanisms of molecular dissemination. He leads the Latin American treatment protocol at the Grupo de America Latina de Oncologia Pediatrica (GALOP) where is member of the Board. He serves as Coordinator of the European Retinoblastoma Group (EURbG). He leads the development of an anti-idiotype vaccine for neuroblastoma in a Latin American protocol. Other areas of interest include pediatric lymphomas and histiocytosis. He is Member of the St Jude Global Pediatric Medicine Department where he is Editor in Chief of Oncopedia at the Cure4kids portal. He is member of the Board at the Latin American Society of Pediatric Oncology (SLAOP)


Subscribe to our newsletter